Reverse Splits

[e-ore]

ENTB - Splitting 1 for 150

On July 2, 2015 Entest Biomedical, Inc. ( the “Company”) filed a Certificate of Change with the Nevada Secretary of State authorizing changes to the Company’s Articles of Incorporation.

The changes are as follows:

(i) Authorized common shares have been reduced from 6,000,000,000 to 500,000,000 authorized shares.

(ii) A 1 for 150 reverse stock split of all issued series of stock with the exception of the Corporation’s authorized Non Voting Convertible Preferred Stock. One share of Common Stock will be issued after the exchange for one hundred and fifty shares of Common Stock issued. One share of each series of preferred Stock (with the exception of the Corporation’s authorized Non Voting Convertible Preferred Stock) will be issued after the exchange for one hundred and fifty shares of each series of Preferred Stock issued

The changes become effective July 27, 2015.

http://archive.fast-edgar.com//20150706/AJZ2W22C2222S2M2222A2WZ28B4G82278272/